[go: up one dir, main page]

FI871052A7 - Nya substituerade tiazoler och oxazoler, dessa foereningar innehaollande laekemedel och foerfarande foer deras framstaellning. - Google Patents

Nya substituerade tiazoler och oxazoler, dessa foereningar innehaollande laekemedel och foerfarande foer deras framstaellning.

Info

Publication number
FI871052A7
FI871052A7 FI871052A FI871052A FI871052A7 FI 871052 A7 FI871052 A7 FI 871052A7 FI 871052 A FI871052 A FI 871052A FI 871052 A FI871052 A FI 871052A FI 871052 A7 FI871052 A7 FI 871052A7
Authority
FI
Finland
Prior art keywords
och
tiazoler
oxazoler
substituerade
nya
Prior art date
Application number
FI871052A
Other languages
English (en)
Other versions
FI871052A0 (fi
FI87777C (fi
FI87777B (fi
Inventor
Manfred Reiffen
Rudolf Hurnaus
Robert Sauter
Wolfgang Grell
Eckhard Rupprecht
Original Assignee
Thomae Gmbh Dr K
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE19863608290 external-priority patent/DE3608290A1/de
Application filed by Thomae Gmbh Dr K filed Critical Thomae Gmbh Dr K
Publication of FI871052A0 publication Critical patent/FI871052A0/fi
Publication of FI871052A7 publication Critical patent/FI871052A7/fi
Application granted granted Critical
Publication of FI87777B publication Critical patent/FI87777B/fi
Publication of FI87777C publication Critical patent/FI87777C/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/22Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/06Antihyperlipidemics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D263/00Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/30Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D263/32Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D265/00Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/281,4-Oxazines; Hydrogenated 1,4-oxazines
    • C07D265/301,4-Oxazines; Hydrogenated 1,4-oxazines not condensed with other rings
    • C07D265/321,4-Oxazines; Hydrogenated 1,4-oxazines not condensed with other rings with oxygen atoms directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/22Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D277/24Radicals substituted by oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/38Nitrogen atoms
    • C07D277/40Unsubstituted amino or imino radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/38Nitrogen atoms
    • C07D277/42Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/38Nitrogen atoms
    • C07D277/44Acylated amino or imino radicals
    • C07D277/46Acylated amino or imino radicals by carboxylic acids, or sulfur or nitrogen analogues thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Obesity (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
FI871052A 1986-03-13 1987-03-11 Foerfarande foer framstaellning av terapeutiskt anvaendbara substituerade tiazoler och oxazoler FI87777C (fi)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
DE19863608290 DE3608290A1 (de) 1986-03-13 1986-03-13 Neue substituierte thiazole und oxazole, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung
DE3608290 1986-03-13
DE3621775 1986-06-28
DE19863621775 DE3621775A1 (de) 1986-03-13 1986-06-28 Neue substituierte thiazole und oxazole, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung

Publications (4)

Publication Number Publication Date
FI871052A0 FI871052A0 (fi) 1987-03-11
FI871052A7 true FI871052A7 (fi) 1987-09-14
FI87777B FI87777B (fi) 1992-11-13
FI87777C FI87777C (fi) 1993-02-25

Family

ID=25841907

Family Applications (1)

Application Number Title Priority Date Filing Date
FI871052A FI87777C (fi) 1986-03-13 1987-03-11 Foerfarande foer framstaellning av terapeutiskt anvaendbara substituerade tiazoler och oxazoler

Country Status (19)

Country Link
US (2) US5457205A (fi)
EP (1) EP0239815B1 (fi)
JP (1) JPH0784446B2 (fi)
KR (1) KR870008876A (fi)
CA (1) CA1296002C (fi)
DE (2) DE3621775A1 (fi)
DK (1) DK168991B1 (fi)
ES (1) ES2040215T3 (fi)
FI (1) FI87777C (fi)
GR (1) GR3002839T3 (fi)
HK (1) HK106494A (fi)
HU (1) HU196974B (fi)
IE (1) IE59800B1 (fi)
IL (1) IL81874A (fi)
MX (1) MX9202818A (fi)
NO (1) NO172849C (fi)
PH (1) PH23996A (fi)
PL (1) PL154772B1 (fi)
PT (1) PT84462B (fi)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3805382A1 (de) * 1988-02-20 1989-08-31 Boehringer Ingelheim Vetmed Verwendung von thiazolen zur leistungssteigerung bei tieren
JP3003148B2 (ja) * 1989-01-05 2000-01-24 藤沢薬品工業株式会社 チアゾール化合物、その製造法およびそれを含有する医薬組成物
HUT70422A (en) * 1991-07-22 1995-10-30 Pfizer Chiral thiazole derivatives and process for preparing them
AU7084294A (en) * 1993-07-14 1995-02-13 Taisho Pharmaceutical Co., Ltd. 5-acetylthiazoline oxime derivative
US6472387B1 (en) 1996-10-07 2002-10-29 Eli Lilly And Company Methods of using compounds as neuro-protective agents
PT971709E (pt) 1996-10-07 2003-09-30 Lilly Co Eli Novos compostos uteis como agentes neuro-protectores
DE69738809D1 (de) * 1996-11-08 2008-08-14 Nippon Chemiphar Co Mittel zur verringerung der eigeweidefette
BR9812857A (pt) 1997-10-06 2000-08-08 Lilly Co Eli Compostos úteis como agentes neuro-protetores
US5972099A (en) * 1997-12-17 1999-10-26 Bayer Corporation Process for preparing organic pigment compositions
US6121300A (en) * 1998-11-10 2000-09-19 Wagle; Dilip R. Reversing advanced glycosylation cross-links using heterocyclic-substituted thiazolium salts
DE60108420T2 (de) * 2000-11-28 2005-12-22 Smithkline Beecham P.L.C., Brentford Morpholinderivate als antagonisten an orexinrezeptoren
DK1633340T3 (da) * 2003-04-15 2011-02-07 Wellstat Therapeutics Corp Forbindelser til behandling af stofskifteforstyrrelser
EP1618086B1 (en) 2003-04-22 2009-12-02 Wellstat Therapeutics Corporation Compounds for the treatment of metabolic disorders
GB0324654D0 (en) * 2003-10-22 2003-11-26 Glaxo Group Ltd Medicinal compounds
TW200526588A (en) * 2003-11-17 2005-08-16 Smithkline Beecham Corp Chemical compounds
JP6063948B2 (ja) * 2011-10-27 2017-01-18 メルク・シャープ・アンド・ドーム・コーポレーションMerck Sharp & Dohme Corp. ベータ3アゴニストおよび中間体を製造するプロセス
US10791890B2 (en) 2018-03-27 2020-10-06 Omachron Intellectual Property Inc. Surface cleaning apparatus

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3225042A (en) * 1962-07-31 1965-12-21 Lilly Co Eli Hydroxymorpholines
US3514465A (en) * 1966-12-30 1970-05-26 Degussa Certain thiazolyl- and pyridinylaminoketones
LU69079A1 (fi) * 1973-12-27 1975-08-20
FI791727A7 (fi) * 1978-06-05 1981-01-01 Ciba Geigy Ag Menetelmä N-alkyloitujen aminoalkoholien valmistamiseksi.
IE50355B1 (en) * 1979-10-20 1986-04-02 Wyeth John & Brother Ltd Morpholine derivatives
GB8418657D0 (en) * 1984-07-21 1984-08-22 Beecham Group Plc Compounds
US4826990A (en) * 1987-09-30 1989-05-02 American Home Products Corporation 2-aryl substituted heterocyclic compounds as antiallergic and antiinflammatory agents

Also Published As

Publication number Publication date
FI871052A0 (fi) 1987-03-11
PT84462B (pt) 1989-10-04
FI87777C (fi) 1993-02-25
IL81874A (en) 1991-01-31
EP0239815B1 (de) 1991-07-24
PL154772B1 (en) 1991-09-30
KR870008876A (ko) 1987-10-21
US5457205A (en) 1995-10-10
NO871028L (no) 1987-09-14
ES2040215T3 (es) 1993-10-16
DK127487D0 (da) 1987-03-12
CA1296002C (en) 1992-02-18
PT84462A (de) 1987-04-01
NO172849C (no) 1993-09-15
US5604225A (en) 1997-02-18
IL81874A0 (en) 1987-10-20
HK106494A (en) 1994-10-14
PL264545A1 (en) 1988-07-21
JPH0784446B2 (ja) 1995-09-13
GR3002839T3 (en) 1993-01-25
MX9202818A (es) 1992-06-30
FI87777B (fi) 1992-11-13
HU196974B (en) 1989-02-28
DE3621775A1 (de) 1988-01-07
JPS62226971A (ja) 1987-10-05
EP0239815A1 (de) 1987-10-07
DE3771541D1 (de) 1991-08-29
DK127487A (da) 1987-09-14
PH23996A (en) 1990-02-09
NO172849B (no) 1993-06-07
DK168991B1 (da) 1994-07-25
HUT44246A (en) 1988-02-29
IE59800B1 (en) 1994-04-06
IE870644L (en) 1987-09-13
NO871028D0 (no) 1987-03-12

Similar Documents

Publication Publication Date Title
FI880546A7 (fi) Nya kolfibriller, foerfarande foer framstaellning daerav och kompositioner innehaollande desamma.
FI873142A7 (fi) Nya benzolsulfonamido -indanylfoereningar, dessa foereningar innehaollande laekemedel och foerfarande foer deras framstaellning.
FI860971A0 (fi) Nya sulfonylaminoetylfoereningar, dessa foereningar innehaollande laekemedel och foerfarande foer deras framstaellning.
FI886005A7 (fi) Nya, sulfhydrylgrupper innehaollande tricykliska laktamer och deras farmakologiska anvaendningsfoerfaranden.
FI892454L (fi) Nya bensimidazolderivat, foerfarande foer framstaellning av desamma och farmaceutisk komposition innehaollande desamma.
FI875727L (fi) Nya oligosackarider, immunogener och vacciner och foerfarande foer framstaellning av saodana oligosackarider, immunogener och vacciner.
FI874323A7 (fi) Nya imidazo-benzoxazinoner, deras framstaellning och dessa foereningar innehaollande laekemedel.
FI872841A0 (fi) Nya kromoforfoereningar, solskyddskompositioner och foerfarande foer hindrande av solbraenna.
FI870274A0 (fi) Nya alkan- och alkoxialkanderivat, foerfarande foer deras framstaellning och dessa foereningar innehaollande bekaempningsmedel foer insekter och kvalster.
FI871052A7 (fi) Nya substituerade tiazoler och oxazoler, dessa foereningar innehaollande laekemedel och foerfarande foer deras framstaellning.
FI882385L (fi) Fosforhaltiga hmg-coa -reduktasinhibitorer, foerfarande foer framstaellning daerav och nya mellanprodukter.
FI883347A7 (fi) Nya 5-aminometylen-2,4 -imidazolidindioner och 5-aminometylen-4-tionoimidazolidin-4-oner.
FI875719A0 (fi) Nya alkansulfonanilidderivat, foerfarande foer deras framstaellning och dessa innehaollande farmaceutiska blandningar.
FI885811L (fi) Nya ammoniumfoereningar, deras framstaellning och anvaendning.
FI882477A7 (fi) Nya alkansulfonanilidderivat, foerfarande foer deras framstaellning och dessa innehaollande farmaceutiska blandningar.
FI875595A7 (fi) Nya bicykliska difosfonatfoereningar, farmaceutiska kompositioner och foerfarande foer behandling av avvikande kalcium- och fosfatmetabolism.
FI881816L (fi) Nya bicykliska foereningar, foerfarande foer deras framstaellning och dessa innehaollande farmaceutiska blandningar.
FI875086A7 (fi) Nya benzotiadiazinfoereningar, foerfarande foer deras framstaellning och dessa innehaollande farmaceutiska blandningar.
FI873917A7 (fi) Nya naftalin- och indanderivat, dessa foereningar innehaollande laekemedel och foerfarande foer deras framstaellning.
FI873934A7 (fi) Nya naftylderivat, dessa foereningar innehaollande laekemedel och foerfarande foer deras framstaellning.
FI873243A0 (fi) Nya 1,4-benzodiazepiner, deras framstaellning och anvaendning.
FI873783A7 (fi) Nya sulfonamido-etylfoereningar, dessa foereningar innehaollande laekemedel och foerfarande foer deras framstaellning.
FI885056L (fi) Nya fluormetoxifenyldihydropyridiner, foerfarande foer deras framstaellning och deras anvaendning i laekemedel.
FI872635A7 (fi) Nya polypeptider, deras framstaellning och anvaendning.
FI883745A7 (fi) Nya kondenserade diazepinoner, foerfarande foer deras framstaellning och dessa foereningar innehaollande laekemedel.

Legal Events

Date Code Title Description
MM Patent lapsed

Owner name: DR. KARL THOMAE GESELLSCHAFT MIT